Chemistree Technology Inc CHMJF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if CHMJF is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.01
- Bid/Ask
- $0.00 / $0.01
- Market Cap
- $44,262.66
- Volume/Avg
- 7,367 / 61,332
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Chemistree Technology Inc through its wholly-owned subsidiaries focused on making investments or acquisitions in areas relating to the United States cannabis sector, focusing on providing turn-key solutions for the United States-regulated cannabis industry. It generates revenue from the United States.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 6
- Website
- https://www.chemistree.ca
Valuation
|
Metric
|
CHMJF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
CHMJF
|
|---|---|
Quick Ratio | 0.07 |
Current Ratio | 0.07 |
Interest Coverage | −0.01 |
Quick Ratio
CHMJF
Profitability
|
Metric
|
CHMJF
|
|---|---|
Return on Assets (Normalized) | −194.60% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −123.28% |
Return on Assets
CHMJF
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Hbrwqnjsh | Kzlcpd | $71.2 Bil | |
ZTS
| Zoetis Inc Class A | Hdzvrswmdt | Rqb | $68.3 Bil | |
HLN
| Haleon PLC ADR | Nfvklpf | Vmlm | $37.0 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Nxlzqplk | Zlhwn | $14.5 Bil | |
VTRS
| Viatris Inc | Fgwcpnrkb | Kdk | $13.4 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Kdnvhlsqc | Ylk | $11.9 Bil | |
CTLT
| Catalent Inc | Ywmnprc | Rvjtfv | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Bfxxljfcj | Hbhd | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Rltjrcw | Tmrkf | $3.6 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Wdrmgchyp | Nzcqrw | $3.5 Bil |